Skip to content

Zevra Therapeutics, Inc. ZVRA Investment Proceeds

Investment Proceeds at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$767.28M+886%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$88M-35.8%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$96M+194%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$83.8M+29.3%
Arrowhead Research logo
Arrowhead ResearchARWR
$115.34M-2.4%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$10M

Other financials

Income statement

See full
Revenue$36.2M+77.5%
Gross profit$34.3M+80.1%
Operating income$52.1M+1,073%
Net income$37.9M+1,323%
EPS (diluted)$0.60+1,100%

Balance sheet

See full
Cash & equivalents$95.6M+156%
Total debt$1.1M-98.1%
Total equity$205.8M+402%
Total assets$278.6M+61.3%

Cash flow

See full
Operating cash flow$6.1M+175%
CapEx$35.0K-64.6%
Free cash flow$6.1M+173%

Valuation

See full
Market cap$773.23M+58.2%
Enterprise value$678.78M+32.5%
P/E6.2×
P/S6.3×-5.7×

Profitability

See full
Gross margin86.1%+7.2pp
Operating margin-103.9%-43.0pp
Net margin101.6%+60.1pp
FCF margin-75%-30.5pp

Returns & leverage

See full
Return on equity100.7%+60.3pp
Debt / equity-1.5×
Current ratio4.9×+1.9×

Where this comes from

Reported directly by Zevra Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments.

The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zevra Therapeutics, Inc.'s investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zevra Therapeutics, Inc.'s investment proceeds?
Zevra Therapeutics, Inc. (ZVRA) reported investment proceeds of $93.97M in Q1 2026.
How has Zevra Therapeutics, Inc.'s investment proceeds changed year-over-year?
Zevra Therapeutics, Inc.'s investment proceeds increased by 422.1% year-over-year, from $18M to $93.97M.
What does investment proceeds mean?
Cash received from sales, maturities, and redemptions of investment securities across all categories.